Proteinkinase Inhibitors (Topics in Medicinal Chemistry, 36) 1st ed. 2021 Edition

Proteinkinase Inhibitors (Topics in Medicinal Chemistry, 36) 1st ed. 2021 Edition

15 $

Delivery time: Maximum to 1 hours

Earn 15 points worth 15 $
Category:

Proteinkinase Inhibitors (Topics in Medicinal Chemistry, 36) 1st ed. 2021 Edition

by Stefan Laufer  (Editor)
 
 

This book reviews the principles of design and examples of successful implementation of proteinkinase inhibitors (PKI), and offers a comprehensive and authoritative overview of the history and latest developments in the field. Chapters written by experts from industry and academia cover the function, structure and topology of Proteinkinases, molecular modelling, disclose how to achieve high level of selectivity for kinase inhibitors, and exploit kinase inhibitors for cancer treatment. Particular attention is given to Inhibitors of c-Jun N-terminal kinase 3, and to covalent Janus Kinase 3 Inhibitors. A case study on Receptor Tyrosine Kinases EGFR, VEGFR, PDGFR is also presented in this book.

Given its breath, this book will appeal to medicinal chemists, students, researchers and professionals alike.

 

Product Details

  • Publisher : Springer; 1st ed. 2021 edition (March 24, 2021)
  • Language : English
  • Digital eBook : 263 pages
 
 
 
 

Related Products